CVS Corp (CVS) 104.19 $CVS Is This Number the S
Post# of 64070
Is This Number the Scariest Healthcare Statistic Out There?
Todd Campbell, The Motley Fool - Motley Fool - Sun Mar 15, 12:01PM CDT
Source: Flickr user Chris Potter Healthcare has no shortage of frightening statistics, but a recent review of U.S. spending on medicine last year by the pharmacy benefit manager Express Scripts contained a particularly scary revelation: Last...
ESRX: 83.49 (+2.12), GILD: 100.96 (+1.35), CVS: 104.19 (+0.93), ABBV: 58.85 (+0.85)
Dollar General Corp. Earnings: It's Grow or Die to Meet the Competition
Rich Duprey, The Motley Fool - Motley Fool - Fri Mar 13, 2:27PM CDT
You'll be seeing more of these stores popping up as the deep discount retailer accelerates its expansion plans. Image source: Flickr via Random Retail. The important information for investors in deep discount retailer Dollar General earlier...
DLTR: 83.44 (+1.53), TGT: 80.50 (+1.32), WMT: 83.13 (+1.23), CVS: 104.19 (+0.93), DG: 75.37 (+1.07), FDO: 79.77 (+0.47)
CVS Caremark Rises 1.38% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Mar 12, 3:51PM CDT
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $101.87 to a high of $103.17. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $102.76 on volume of 3.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 104.19 (+0.93)
After Yesterday's Rally of 1.38% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Mar 12, 3:51PM CDT
CVS Caremark (NYSE:CVS) traded in a range yesterday that spanned from a low of $101.87 to a high of $103.17. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $102.76 on volume of 3.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CVS: 104.19 (+0.93)
Rite Aid's New Harrisburg Store to Extend Wellness Program - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 11, 11:00AM CDT
Rite Aid (RAD) announced the introduction of a brand new outlet in Harrisburg.
HLF: 34.24 (-1.72), WBA: 86.23 (+2.51), CVS: 104.19 (+0.93), RAD: 7.43 (-0.02)
Better Buy: Rite Aid Corp. Versus CVS Health
Todd Campbell, The Motley Fool - Motley Fool - Tue Mar 10, 6:01AM CDT
An ever-aging and increasingly insured population means that prescription medicine volume is going to climb for years to come. Two of the companies that are perfectly positioned to profit from that tidal wave of baby boomer demand are Rite Aid...
CVS: 104.19 (+0.93), RAD: 7.43 (-0.02)
How PayPal Is Fighting Back Against Apple Pay
Adam Levy, The Motley Fool - Motley Fool - Mon Mar 09, 3:29PM CDT
2015 is already shaping up to be the year when mobile payments move out of Starbucks and into the mainstream. Apple released its payment service last fall, and Samsung and Google just announced payment platforms of their own at Mobile...
SBUX: 94.02 (+0.73), EBAY: 59.52 (+0.45), WMT: 83.13 (+1.23), CVS: 104.19 (+0.93), BBY: 41.74 (+1.21), GOOGL: 562.68 (+9.68), GOOG: 555.72 (+8.40), AAPL: 124.12 (+0.53)
Rite Aid's (RAD) Key Sales Metrics for February Rise 3.3% - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 09, 2:40PM CDT
Drugstore chain retailer, Rite Aid Corporation (RAD) came up with healthy sales results for the month of February.
HLF: 34.24 (-1.72), WBA: 86.22 (+2.50), CVS: 104.19 (+0.93), RAD: 7.43 (-0.02)
Active Equities to Watch in the Consumer Staples Sector -- Rite Aid, CVS Health, Colgate-Palmolive, Kimberly-Clark, and Clorox
PR Newswire - Mon Mar 09, 8:50AM CDT
Editor Note: For more information about this release, please scroll to bottom.
CLX: 109.18 (+0.41), KMB: 106.43 (+0.64), CVS: 104.19 (+0.93), CL: 68.74 (+0.28), RAD: 7.43 (-0.02)
Wal-Mart To Benefit From Currency Risk Environment
Morgan Myrmo - at Seeking Alpha - Sat Mar 07, 8:01AM CST
TGT: 80.50 (+1.32), WMT: 83.13 (+1.23), CVS: 104.19 (+0.93), COST: 149.64 (+0.36)
Target: What Slowing Dividend Growth Means For Investors
Eli Inkrot - at Seeking Alpha - Fri Mar 06, 2:20PM CST
JPM: 61.63 (+0.63), USB: 44.78 (+0.49), TGT: 80.50 (+1.32), CVS: 104.19 (+0.93), WFC: 55.59 (+0.25)
Here’s a Reason Rite Aid (RAD) Stock Fell Today
at The Street - Thu Mar 05, 3:05PM CST
Rite Aid (RAD) stock was lower today after the company issued its same-store-sales results for February, which increased year-over-year but slowed down from January.
CVS: 104.19 (+0.93), RAD: 7.43 (-0.02)
CVS: Will Strong Dividend Growth Provide Solid Returns?
Eli Inkrot - at Seeking Alpha - Thu Mar 05, 11:14AM CST
CVS: 104.19 (+0.93)
CVS Caremark declares $0.35 dividend
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 9:48AM CST
CVS: 104.19 (+0.93)
CVS Health Wins Over Analysts As Significant Growth Expected In The Next 5 Years
Equity Watch - at Seeking Alpha - Wed Mar 04, 8:17AM CST
GILD: 100.96 (+1.35), CVS: 104.19 (+0.93)
Cardinal Health Set to Buy Cordis, Shares Hit 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 10:26AM CST
Cardinal Health Inc. (CAH) hit a 52-week high of $90.49 on Mar 2, 2015, after the company announced plans to acquire Cordis, a unit of Johnson & Johnson (JNJ).
JNJ: 100.64 (+1.43), CAH: 89.74 (+1.62), CVS: 104.19 (+0.93), HSIC: 139.65 (+3.28)
Horizon Pharma Soars On Q4 Beat, Guidance Raise
at Investor's Business Daily - Fri Feb 27, 10:48AM CST
Specialty drugmaker Horizon Pharma (HZNP) beat analysts' Q4 expectations and raised its 2015 guidance Friday, sending its stock up 10% to a new high. Horizon's revenue in the quarter more than tripled to $103.8 million, about $8 million above...
ESRX: 83.49 (+2.12), AZN: 68.90 (+1.55), HZNP: 22.21 (-0.26), CVS: 104.19 (+0.93)
Catamaran EPS Tops, But Stock Falls On Weak Guidance
at Investor's Business Daily - Thu Feb 26, 10:59AM CST
Catamaran (CTRX) surpassed fourth-quarter earnings and sales estimates on Thursday, but shares sank on its weak full-year EPS outlook. The provider of pharmacy benefit management services saw adjusted earnings climb 19.6% to 67 cents a share in Q4,...
ESRX: 83.49 (+2.12), CTRX: 49.39 (+1.15), BRLI: 34.44 (+0.74), AAC: 28.27 (+0.53), CVS: 104.19 (+0.93), RAD: 7.43 (-0.02)
Impeccable Quality But There Are No Bargains Today In The S&P 500 Consumer Staples Sector: Part 8
Chuck Carnevale - at Seeking Alpha - Wed Feb 25, 11:00AM CST
WFM: 54.52 (+0.31), KO: 40.07 (+0.16), DPS: 76.93 (+0.24), PM: 77.57 (-0.08), AVP: 7.29 (-0.43), MKC: 72.24 (+0.26), CAG: 34.17 (+0.23), CVS: 104.19 (+0.93), COST: 149.64 (+0.36), PG: 83.20 (+1.37), GIS: 52.18 (+0.03), BF.B: 88.95 (+0.32)
Billions on the Line in the Next Drug Pricing War
Keith Speights, The Motley Fool - Motley Fool - Tue Feb 24, 7:02AM CST
Source: Gilead Sciences One win whets the appetite for another. That certainly seems to be the case for the nation's two largest pharmacy benefits managers, Express Scripts and CVS Health . After scoring a victory in bringing hepatitis C...
ESRX: 83.49 (+2.12), GILD: 100.96 (+1.35), CVS: 104.19 (+0.93), REGN: 447.29 (+17.91)